What is Transitional Cell Cancer?

A rare kind of cancer that starts in the lining of the upper urinary tract is called transitional cell carcinoma of the renal pelvis and ureter. The renal pelvis, the part/area of the kidney where urine gathers before moving on to the ureter, and the ureter, through which urine is transported from the kidney (urinary tract) to the bladder via a tube, are all parts of the upper urinary tract. This cancer develops from specialized cells called urothelial cells, also known as transitional cells, which line the urinary tract.

Although this cancer affects structures within the kidney region, it is different from the more common kidney cancer known as renal cell carcinoma. Instead, transitional cell cancer behaves more like bladder cancer because both originate from urothelial cells. For this reason, it is often referred to as upper tract urothelial carcinoma (UTUC).

Ureteral transitional cell carcinomas are quite rare, accounting for only a small proportion of urinary tract cancers. Nonetheless, when detected early, this can result in good treatment prospects. This cancer is known to have been treated by means of innovations in imaging technology and medication.

The urinary system is a vital organ system that helps remove waste products and fluids. This is done by purifying blood, which the kidneys do. Then this purified blood is filtered, producing urine that passes through the renal pelvis, down the ureters, and finally into the bladder. Cancer can develop in the renal pelvis and the ureteral walls. This can cause difficulties in the proper functioning of this system and can lead to many urinary problems.

Understanding the causes, symptoms, diagnostic methods, and treatment options for transitional cell cancer is essential for early detection and effective care.

What are the Types of Transitional Cell Cancer?

Most cancers of the renal pelvis and ureter originate from transitional (urothelial) cells. However, these cancers may vary in behavior, growth patterns, and aggressiveness.

Low-Grade Transitional Cell Carcinoma

Low-grade tumors tend to grow slowly and are less likely to invade deeper layers of tissue. These cancers often remain confined to the lining of the urinary tract and have a lower risk of spreading.

High-Grade Transitional Cell Carcinoma

High-grade tumors are more aggressive and are more likely to invade/infiltrate surrounding tissues or spread to nearby lymph nodes and distant organs. These cancers require prompt and intensive treatment.

Papillary Urothelial Carcinoma

Papillary tumors grow in finger-like projections into the urinary tract. They may remain superficial or become invasive depending on their grade.

Flat Carcinoma (Carcinoma in Situ)

This form involves abnormal cancer cells spreading across the lining of the urinary tract without forming a visible tumor mass. It is often aggressive and requires early treatment.

What are the Primary Symptoms & Causes of Transitional Cell Cancer?

Symptoms of Transitional Cell Cancer

The signs/symptoms of transitional cell cancer of the renal pelvis and ureter are often related to irritation or blockage of the urinary tract. In many cases, the earliest sign is blood in the urine.

Common symptoms include:

• Blood in the urine, or hematuria, which may appear pink, red, or brown
• Pain/ache in the lower back or side (flank pain)
• Frequent urination
• Pain or burning during urination
• Urinary urgency
• Fatigue
• Unexplained weight loss
• Recurrent urinary tract infections

Sometimes the disease may not cause symptoms in its early stages and may be discovered during imaging tests performed for other medical conditions.

Any persistent urinary symptoms or blood in the urine need evaluation by a healthcare professional.

Causes of Transitional Cell Cancer

Transitional cell cancer occurs when mutations occur in the urothelial cells of the renal pelvis and ureter. This mutation causes the cells to grow in an uncontrolled manner.

The uncontrolled cells then form tumors that can invade or infiltrate other tissues and spread to other parts of the patient’s body via the bloodstream and lymphatic system.

Although the exact cause of these mutations is not always known, several environmental and lifestyle factors are associated with an increased risk.

What increases the risk of Transitional Cell Cancer?

Smoking

Cigarette/bidi smoking is one of the strongest Urinary tract transitional cell cancer risk factors. Harmful chemicals from tobacco smoke are absorbed into the bloodstream and filtered by the kidneys, exposing the urinary tract lining to carcinogens.

Occupational Chemical Exposure

Workers exposed to certain industrial chemicals, such as aromatic amines used in dye, rubber, leather, and textile industries, may have a higher risk of developing urothelial cancers.

Chronic Inflammation

Long-standing inflammation or urinary tract infections may increase cancer risk.

Previous Bladder Cancer

Patients with bladder cancer are at a higher risk of developing cancer in the renal pelvis or ureter because the entire urothelial lining may be affected.

Certain Medications and Herbal Products

Long-term use of some pain medications or herbal compounds containing aristolochic acid has been associated with increased risk.

Genetic Factors

Certain inherited conditions may increase susceptibility to urothelial cancers.

How is Transitional Cell Cancer Diagnosed & Tested?

Early detection of transitional cell cancer is vital for proper treatment. Several tests are conducted by physicians to confirm that cancer is present and to ascertain its stage.

Medical History & Physical Examination

Physicians start by reviewing the patient's symptoms and medical history. Physical examination can also help detect signs of kidney or urinary tract abnormalities.

Urine Tests

A urinalysis is likely to detect blood in the urine, while urine cytology can show abnormal cells in the urine that may be cancerous.

Imaging Tests

CT Urography

A Computed Tomography (CT) scan of the urinary tract can provide detailed images of the kidneys, ureters, and bladder. It can be used to diagnose tumors, urinary tract blockages, and other abnormalities.

Ultrasound

Ultrasound, a diagnostic action that uses sound waves to produce/develop images of the kidneys and surrounding areas, can be the best option for diagnosing a mass and hydronephrosis, a swelling of the patient’s kidney caused by a buildup of urine.

MRI

Magnetic resonance imaging may be used when CT scans are not suitable or when more detailed soft tissue imaging is needed.

Ureteroscopy

Ureteroscopy is another option, which involves a thin flexible scope that is inserted through the urethra and bladder into the ureter. This allows doctors to directly visualize tumors and obtain biopsy samples.

Biopsy

Using this procedure, a small tissue sample is taken from the suspected tumor for examination through a digital microscope to confirm the diagnosis and determine the cancer type and grade.

Retrograde Pyelography

In this imaging test, contrast dye is injected into the ureter to highlight the renal pelvis and ureter on X-rays. It helps detect abnormalities or tumors in the upper urinary tract.

How is Transitional Cell Cancer Staged from Stage I to Stage IV?

Staging describes how far cancer has spread. It helps guide treatment planning and predict outcomes.

• Stage I: This stage shows that cancer is confined to the inner lining (interior cover) of the renal pelvis or ureter.
• Stage II: The tumor has developed/grown into deeper tissue layers of the renal pelvis or ureter.
• Stage III: Cancer has spread into the surrounding fat or nearby lymph nodes.
• Stage IV: This stage shows the cancer has spread or metastasized to distant/remote organs such as the lungs, liver, or bones.

Early-stage cancers are often highly treatable, while advanced-stage cancers require more comprehensive treatment.

What Treatment Options exist for Transitional Cell Cancer?

Treatment for transitional cell cancer depends on the stage, grade, tumor location, and the patient’s overall health.

Surgery

Surgery is the most effective and commonly used treatment for localized tumors.

Nephroureterectomy

This procedure helps remove the affected kidney, the ureter, and a small portion of the bladder. It is the standard treatment for many cases of upper urinary tract urothelial cancer.

Segmental Ureterectomy

In some cases, only the affected portion of the ureter is removed while preserving the rest of the urinary tract.

Endoscopic Tumor Removal

For small, low-grade tumors, minimally invasive endoscopic procedures may be used to remove tumors through a ureteroscope.

Chemotherapy

Such a therapy uses powerful drugs to destroy cancer cells. It may be used:

• Before surgery to shrink tumors
• After surgical treatment to lessen the risk of recurrence
• As the primary treatment for advanced cancer

Chemotherapy may be given intravenously or directly into the urinary tract in selected cases.

Immunotherapy

Immunotherapy helps the body's immune system recognize and attack cancer cells. It is increasingly used in advanced urothelial cancers.

Targeted Therapy

Targeted drugs attack specific molecular abnormalities within cancer cells. These therapies may be recommended when tumors have certain genetic mutations.

Radiation Therapy

This therapy uses high-energy beams to damage cancer cells, and it may be an option when surgery is not possible or to relieve symptoms in advanced cancer.

What complications are associated with Transitional Cell Cancer?

Complications may arise from the disease itself or from treatment.

Possible complications include:

• Urinary obstruction
• Kidney dysfunction
• Recurrence of cancer
• Spread of cancer to other organs
• Side effects from chemotherapy or radiation therapy

Regular follow-up care helps detect complications early and manage them effectively.

What is the long-term prognosis and recurrence rate for Transitional Cell Cancer?

The prognosis for transitional cell cancer of the renal pelvis and ureter depends largely on the stage and grade of the tumor at diagnosis.

Patients with early-stage, low-grade tumors generally have favorable outcomes after surgery. However, high-grade or advanced-stage tumors carry a higher risk of recurrence and metastasis.

Because urothelial cancers may recur in other parts of the urinary tract, long-term monitoring is important. Follow-up care may include:

• Imaging tests
• Urine cytology
• Endoscopic examinations
• Blood tests

with early diagnosis and effective treatment, many patients achieve good long-term outcomes.

How can early screenings reduce the risk of Transitional Cell Cancer?

Although transitional cell cancer cannot always be prevented, certain steps can help reduce the risk.

The preventive strategies involve:

• Refraining from smoking and using tobacco
• Avoiding toxic chemicals at work
• Hydrating sufficiently
• Medical check-up in case of urinary problems
• Periodic screening for those with a history of bladder cancer

Healthy lifestyle choices and routine medical checkups can contribute to early detection and improved outcomes.

Why choose Tender Palm Super-Speciality Hospital for Transitional Cell Cancer Treatment in Lucknow, India?

Tender Palm Super-Speciality Hospital offers advanced Transitional Cell Cancer treatment in Lucknow, India, at an affordable cost. We have a team of experienced urological surgeons and oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including transurethral resection, radical cystectomy, and chemotherapy. Our Urology and Oncology team has decades of experience in successfully treating Transitional Cell Cancer in Lucknow, India.

To seek an Expert consultation for Transitional Cell Cancer Treatment in Lucknow, India:

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back